Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Benralizumab Treatment on Circulating Dendritic Cells in Patients With Eosinophilic Asthma

NCT03652376 is registered in ClinicalTrials.gov with University of Rostock as lead sponsor.

NCT NCT03652376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03652376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Benralizumab Treatment on Circulating Dendritic Cells in Patients With Eosinophilic Asthma
Lead sponsor
University of Rostock
Phase
Phase 4
Overall status
Unknown status
Start date
September 1, 2018
Completion date
December 31, 2019
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe eosinophilic asthma